[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Editorial Board
Advisory Board
Aims & Scope
Journal News
Articles archive::
All Issues
Current Issue
Articles in press
For Authors::
Submission Instruction
For Reviewers::
Reviewers Section
Subscription::
Subscription Form
News& Events::
Journal News
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
Top 10 contents
Inform others
Ethics & Permissions::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 12, Issue 1 (Spring 2015) ::
Sci J Iran Blood Transfus Organ 2015, 12(1): 39-45 Back to browse issues page
The possibility of miR-20a/b & miR-93 role in differentiation of naïve CD4+ to Th17 cells in multiple sclerosis
R. Naghavian , M.A. Honardoost , A. Hosseini , K. Ghaedi , M. Etemadifar , M. Nasr Esfahani , M. Ganjalikhani Hakemi
Keywords: Key words : Multiple Sclerosis, MicroRNAs, Th17 Cells, Autoimmune Diseases
Full-Text [PDF 315 kb]   (1851 Downloads)     |   Abstract (HTML)  (7503 Views)
Type of Study: Research | Subject: Imunology
Published: 2015/04/7
Full-Text:   (1454 Views)
    References :  
  1. Calabresi PA. Diagnosis and management of multiple sclerosis. Am Fam Physician 2004; 70(10): 1935-44.
  2. Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, Stewart GJ, et al. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 2010; 5(8): e12132.
  3. Goldenberg MM. Multiple sclerosis review. P T 2012; 37(3): 175-84.
  4. Nakahara J, Maeda M, Aiso S, Suzuki N. Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy. Clin Rev Allergy Immunol  2012; 42(1): 26-34.
  5. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6(11): 1123-32.
  6. Stockinger B, Veldhoen M. Differentiation and function  of  Th17  T  cells.  Curr  Opin Immunol 2007;
 
19(3): 281-6.
  1. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The Orphan Nuclear Receptor ROR gammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126(6): 1121-33.
  2. Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen J, Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009; 132(Pt 12): 3329-41.
  3. Edwards L, Robins R, Constantinescu C. Th17/Th1 phenotype in demyelinating disease. Cytokine 2010; 50(1): 19-23.
  4. Qian G, Qin X, Zang YQ, Ge B, Guo TB, Wan B, et al. High doses of α-galactosylceramide potentiate experimental autoimmune encephalomyelitis by directly enhancing Th17 response. Cell Res 2010; 20(4): 480-91.
  5. Doodes PD, Cao Y, Hamel KM, Wang Y, Rodeghero RL, Mikecz K, et al. IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis. J Immunol 2010; 184(3): 1552-9.
  6. von Delwig A, Locke J, Robinson JH, Ng WF. Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis. Arthritis Rheum 2010; 62(1): 143-9.
  7. Fujishima S, Watanabe H, Kawaguchi M, Suzuki T, Matsukura S, Homma T, et al. Involvement of IL-17F via the induction of IL-6 in psoriasis. Arch Dermatol Res 2010; 302(7): 499-505.
  8. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128(5): 1207-11.
  9. Emamaullee JA, Davis J, Merani S, Toso C, Elliott JF, Thiesen A, et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009; 58(6): 1302-11.
  10. Murdaca G, Colombo BM, Puppo F. The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern Emerge Med 2011; 6(6): 487-95.
  11. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281-97.
  12. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136(2): 215-33.
  13. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10(2): 111-22.
  14. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009; 136(1): 26-36.
  15. Alevizos I, Illei GG. MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease. Autoimmun Rev 2010; 9(9): 618-21.
  16. Furer V, Greenberg JD, Attur M, Abramson SB, Pillinger MH. The role of microRNA in rheumatoid
    arthritis and other autoimmune diseases. Clin  Immunol 2010; 136(1): 1-15    .
  17. Hirahara K, Ghoreschi K, Laurence A, Yang X-P, Kanno Y, O'Shea JJ. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev 2010; 21(6): 425-34.
  18. Sundrud MS, Koralov S. Negative Regulation of TH17 Differentiation. In: Shuiping J. TH17 Cells in Health and Disease. USA: Springer; 2011. p. 129-55.
  19. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk--database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J Biomed Inform 2011; 44(5): 839-47.
  20. Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014; 42(Database issue): D68-73.
  21. Lindberg RL, Hoffmann F, Mehling M, Kuhle J, Kappos L. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing–remitting multiple sclerosis patients. Eur J Immunol 2010; 40(3): 888-98.
  22. Steiner DF, Thomas MF, Hu JK, Yang Z, Babiarz JE, Allen CD, et al. MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells. Immunity 2011; 35(2): 169-81.
  23. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007; 282(13): 9358-63.
  24. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29(2): 117-29.
  25. Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, et al. HIF1alpha–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 2011; 208(7): 1367-76.
 
 
 
 
 
 

 

 
 
 
 
 
Sci J Iran Blood Transfus Organ 2015; 12(1): 39-45
 
Original  Article
 
 

The possibility of miR-20a/b & miR-93 role in
differentiation of naïve CD4+ to Th17 cells
in multiple sclerosis
 
Naghavian R.1, Honardoost M.A.1, Hosseini A.1, Ghaedi K.2,3, Etemadifar M.4,
Nasr Esfahani M.H.3, Ganjalikhani Hakemi M.5,6
 
 
1University of Isfahan, Isfahan, Iran
2School of Science, University of Isfahan, Isfahan, Iran
3Department of Cellular Biotechnology at Cell Science Research Center, ACECR, Royan Institute for Biotechnology, Isfahan, Iran
4Isfahan University of Medical Sciences, Isfahan, Iran
5Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
6Cellular & Molecular Immunology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
 
Abstract
Background and Objectives
Multiple sclerosis (MS) is an autoimmune neurodegenerative disease in which the body’s natural defense system attacks myelin on neuronal cells. One of the most important immune system cells involved in MS is Th17 which is one of the main cells involved in most of autoimmune diseases. Recently, microRNAs (miRNAs) have been remarkably used in treating many kinds of diseases. MicroRNAs are endogenous 22-25 nt RNAs playing an important regulatory roles in cellular and developmental processes.
 
Materials and Methods
The goal of this article is to determine miRNAs which possibly have the most effect in the pathway of differentiation to Th17 cells by using miRWalk database and candidate microRNAs that can suppress this pathway and limit the disease’s symptoms. Our in-silico studies identified the possible role of several miRNAs in differentiation of naïve CD4+ cells to Th17 cells.
 
Results
miR-93,miR-20a/b are probably applicable to inhibit the differentiation of naïve T cells into Th17 cells to reduce the progress of MS and also to be used as markers of diagnosis of MS in early stages.
 
Conclusions
According to our results miR-20a/b&miR-93 can possibly be the key miRNAs, inhibiting the progression of MS by preventing the differentiation to Th17 cells.
 
Key words: Multiple Sclerosis, MicroRNAs, Th17 Cells, Autoimmune Diseases
 
 
Received: 11 Mar 2014
Accepted: 24 Sep 2014
 

 

Correspondence: Ghaedi K, PhD of Molecular Biology. Associate Professor of School of Science , Isfahan University of Medical Sciences & Department of Cellular Biotechnology at Cell Science Research Center, ACECR, Royan Institute for Biotechnology.
Postal code: 81746-73441, Isfahan, Iran. Tel: (+98311) 7932479 ; Fax: (+98311) 7932456
E-mail: kamranghaedi@yahoo.com
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Naghavian R, Honardoost M, Hosseini A, Ghaedi K, Etemadifar M, Nasr Esfahani M et al . The possibility of miR-20a/b & miR-93 role in differentiation of naïve CD4+ to Th17 cells in multiple sclerosis. Sci J Iran Blood Transfus Organ 2015; 12 (1) :39-45
URL: http://bloodjournal.ir/article-1-845-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 12, Issue 1 (Spring 2015) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.09 seconds with 39 queries by YEKTAWEB 4645